IL148798A0 - Sequences characteristic of bladder cancer - Google Patents

Sequences characteristic of bladder cancer

Info

Publication number
IL148798A0
IL148798A0 IL14879800A IL14879800A IL148798A0 IL 148798 A0 IL148798 A0 IL 148798A0 IL 14879800 A IL14879800 A IL 14879800A IL 14879800 A IL14879800 A IL 14879800A IL 148798 A0 IL148798 A0 IL 148798A0
Authority
IL
Israel
Prior art keywords
bladder cancer
sequences characteristic
sequences
characteristic
bladder
Prior art date
Application number
IL14879800A
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of IL148798A0 publication Critical patent/IL148798A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14879800A 1999-09-27 2000-09-27 Sequences characteristic of bladder cancer IL148798A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15615399P 1999-09-27 1999-09-27
PCT/US2000/041005 WO2001022864A2 (en) 1999-09-27 2000-09-27 Sequences characteristic of bladder cancer

Publications (1)

Publication Number Publication Date
IL148798A0 true IL148798A0 (en) 2002-09-12

Family

ID=22558336

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14879800A IL148798A0 (en) 1999-09-27 2000-09-27 Sequences characteristic of bladder cancer

Country Status (5)

Country Link
EP (1) EP1248855A4 (en)
AU (1) AU1492601A (en)
CA (1) CA2385893A1 (en)
IL (1) IL148798A0 (en)
WO (1) WO2001022864A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
AU2002338431A1 (en) * 2001-04-04 2002-11-05 Quark Biotech, Inc. Sequence characteristics of bladder cancer
PT2444505T (en) 2004-07-23 2017-01-13 Pacific Edge Ltd Urine markers for detection of bladder cancer
EP2292796A1 (en) * 2005-02-10 2011-03-09 Oncotherapy Science, Inc. Method of diagnosing bladder cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856136A (en) * 1996-07-03 1999-01-05 Incyte Pharmaceuticals, Inc. Human stem cell antigens
DE19818619A1 (en) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents

Also Published As

Publication number Publication date
WO2001022864A3 (en) 2001-11-01
WO2001022864A9 (en) 2002-12-12
AU1492601A (en) 2001-04-30
CA2385893A1 (en) 2001-04-05
EP1248855A2 (en) 2002-10-16
EP1248855A4 (en) 2004-12-22
WO2001022864A2 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU7680300A (en) Human dna sequences
AU2002319338A1 (en) Cancer specific oligosaccharide sequences and use thereof
EP1320376A4 (en) Treatment of prostate cancer
SI1176964T1 (en) Uses of et743 for treating cancer
AU7129700A (en) Ovarian tumor sequences and methods of use therefor
HUP0200805A3 (en) Improved cancer treatment with temozolomide
IL148798A0 (en) Sequences characteristic of bladder cancer
IL149093A0 (en) Short segments of dap-kinase
AU9402401A (en) Treatment of cancers
EP1218407A4 (en) Uses of kappa-conotoxin pviia
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU2002338431A1 (en) Sequence characteristics of bladder cancer
PL350963A1 (en) Use of arylalkanoylpyridazines
GB0008801D0 (en) Sequences
GB0210912D0 (en) Sequences encoding human neoplastic marker
EP1225222A4 (en) Novel tumor suppressor gene
AU2001289127A1 (en) Tumor treatment
AU1199201A (en) Breast tumor sequences and methods of use therefor
HUP0202614A3 (en) Use of thienopyrimidines
GB9911183D0 (en) Treatment of cancers
GB0111194D0 (en) Sequences
GB9911346D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers